Inge Marie Svane
Clinical Professor
- Published
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., Linette, G. P., Thomas, L., Lorigan, P., Grossmann, K. F., Hassel, J. C., Maio, M., Sznol, M., Ascierto, P. A., Mohr, P., Chmielowski, B. & 8 others, , Apr 2015, In: Lancet Oncology. 16, 4, p. 375-84 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
Jensen, C., Madsen, D. H., Hansen, M., Schmidt, H., Svane, Inge Marie, Karsdal, M. A. & Willumsen, N., 2018, In: Journal for ImmunoTherapy of Cancer. 6, 1, p. 1-10 10 p., 152.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.Research output: Contribution to journal › Review › Research › peer-review
- Published
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Ascierto, P. A., Del Vecchio, M., Mackiewicz, A., Robert, C., Chiarion-Sileni, V., Arance, A., Lebbé, C., Svane, I. M., Mcneil, C., Rutkowski, P., Loquai, C., Mortier, L., Hamid, O., Bastholt, L., Dreno, B., Schadendorf, D., Garbe, C., Nyakas, M., Grob, J. J., Thomas, L. & 10 others, , 2020, In: Journal for ImmunoTherapy of Cancer. 8, 1, e000391.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer
dqp123, dqp123, Kjeldsen, J. W., Andersen, R., Westergaard, M. C. W., Bianchi, V., Legut, M., Attaf, M., Szomolay, B., Ott, S., Dolton, G., Lyngaa, R., Hadrup, S. R., Sewell, A. K. & Svane, Inge Marie, 2017, In: Clinical Cancer Research. 23, 19, p. 5779-5788Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy
Steiniche, T., Vestergaard Danielsen, A., Wang, Z., Feng, Y., Switten Nielsen, P., Bastholt, L., Schmidt, H., Svane, Inge Marie, Dolled-Filhart, M., Emancipator, K., Weiner, R., Busch-Sørensen, M. & Zhou, W., 2017, In: Journal of the European Academy of Dermatology and Venereology. 31, 7, p. e319-e321Research output: Contribution to journal › Comment/debate › Research
- Published
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide Super-Agonist Enhances T-Cell Responses to Melanoma
Galloway, S. A. E., Dolton, G., Attaf, M., Wall, A., Fuller, A., Rius, C., Bianchi, V., Theaker, S., Lloyd, A., Caillaud, M. E., Svane, Inge Marie, dqp123, dqp123, Cole, D. K., Szomolay, B., Rizkallah, P. & Sewell, A. K., 2019, In: Frontiers in Immunology. 10, 18 p., 319.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial
Jørgensen, N. G., Klausen, U., Grauslund, J. H., Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 11 p., 595035.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment
Bendtsen, S. K., Perez Penco, Maria, Hübbe, M. L., Martinenaite, E., Orebo Holmström, M., Weis-Banke, S. E., Grønne Dahlager Jørgensen, N., Jørgensen, M. A., Munir Ahmad, S., Jensen, K. M., Friese, C., Lundsager, M. T., Johansen, A. Z., Carretta, M., Ødum, Niels, Met, Özcan, Svane, Inge Marie, Madsen, Daniel Hargbøl & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2026020.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations
Rius, C., Attaf, M., Tungatt, K., Bianchi, V., Legut, M., Bovay, A., dqp123, dqp123, Thor Straten, P., Peakman, M., Svane, Inge Marie, Ott, S., Connor, T., Szomolay, B., Dolton, G. & Sewell, A. K., 2018, In: The Journal of Immunology. 200, 7, p. 2263-2279Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peripheral memory T cells specific for Arginase-1
Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
Mork, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N., Sorensen, A. B., Rasmussen, I. S., Andreasen, L. V., Yde, C. W., Trolle, T., Garde, C., Friis-Nielsen, J., Norgaard, N., Christensen, D., Kringelum, J. V., dqp123, dqp123, Hadrup, S. R. & Svane, Inge Marie, 31 Dec 2022, In: OncoImmunology. 11, 1, 15 p., 2023255.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Ascierto, P. A., Avallone, A., Bhardwaj, N., Bifulco, C., Bracarda, S., Brody, J. D., Buonaguro, L., Demaria, S., Emens, L. A., Ferris, R. L., Galon, J., Khleif, S. N., Klebanoff, C. A., Laskowski, T., Melero, I., Paulos, C. M., Pignata, S., Ruella, M., Svane, I. M., Taube, J. M. & 3 others, , 2022, In: Journal of Translational Medicine. 20, 1, 257.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)
Chen, I. M., Donia, M., Chamberlain, C. A., Jensen, Agnete Witness Præst, Draghi, A., Theile, S., Madsen, K., Hasselby, Jane Preuss, Toxværd, A., Høgdall, Estrid Vilma Solyom, Lorentzen, T., Wilken, E. E., Geertsen, P., Svane, Inge Marie, Johansen, Julia Sidenius & Nielsen, D., 2023, In: European Journal of Cancer. 180, p. 125-133 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer
Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., 2016, In: Clinical Genitourinary Cancer. 14, 6, p. e559-e568Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Predictors of responses to immune checkpoint blockade in advanced melanoma
Jacquelot, N., Roberti, M. P., Enot, D. P., Rusakiewicz, S., Ternès, N., Jegou, S., Woods, D. M., Sodré, A. L., Hansen, M., Meirow, Y., Sade-Feldman, M., Burra, A., Kwek, S. S., Flament, C., Messaoudene, M., Duong, C. P. M., Chen, L., Kwon, B. S., Anderson, A. C., Kuchroo, V. K. & 30 others, , 2017, In: Nature Communications. 8, 13 p., 592.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Principles of adoptive T cell therapy in cancer
Met, Özcan, Jensen, K. M., Chamberlain, C. A., dqp123, dqp123 & Svane, Inge Marie, 11 Jan 2019, In: Seminars in Immunopathology. 41, 1, p. 49–58Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma
Gokuldass, A., Draghi, A., Papp, K., Borch, T. H., Nielsen, M., Westergaard, M. C. W., Andersen, R., Schina, A., Bol, K. F., Chamberlain, C. A., Presti, M., Met, Özcan, Harbst, K., Lauss, M., Soraggi, S., Csabai, I., Szállási, Z., Jönsson, G., Svane, Inge Marie & dqp123, dqp123, 2020, In: Cancers. 12, 11, p. 1-15 15 p., 3344.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy
Pedersen, S., Holmstroem, R. B., von Heymann, A., Tolstrup, L. K., Madsen, K., Petersen, M. A., Haslund, C. A., Ruhlmann, C. H., Schmidt, H., Johansen, Christoffer, Svane, Inge Marie & Ellebaek, E., 2023, In: Acta Oncologica. 62, 1, p. 62-69 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol
Spindler, N. J., Persson, Gitte F., Theile, S., Nielsen, D. L., Høgdall, Estrid Vilma Solyom, Al-Farra, G., Hendel, Helle Westergren, Lorentzen, T., Svane, Inge Marie, Lindberg, H. & Eefsen, R. L., 2023, In: BMJ Open. 13, 1, 8 p., e063500.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Randomized Phase II Study of Nivolumab with or Without Ipilimumab Combined with Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
Chen, I. M., Johansen, Julia Sidenius, Theile, S., Hjaltelin, Jessica Xin, Novitski, Sif Ingibergsdóttir, Brunak, Søren, Hasselby, Jane Preuss, Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsøe, Christian, Hermann, K. L., Svane, Inge Marie & Nielsen, Dorte Lisbet, 2022, In: Journal of Clinical Oncology. 40, 27, p. 3180-3189Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens
Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4054758
Most downloads
-
277
downloads
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
258
downloads
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
189
downloads
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Research output: Contribution to journal › Journal article › Research › peer-review
Published